wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34180815-060807B4-1B01-400D-A0A0-B6B46774FA04
Q34180815-060807B4-1B01-400D-A0A0-B6B46774FA04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-060807B4-1B01-400D-A0A0-B6B46774FA04
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
P1476
Q34180815-060807B4-1B01-400D-A0A0-B6B46774FA04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-060807B4-1B01-400D-A0A0-B6B46774FA04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a3f3f3c0236a08c6ec7c1300d6d177c73ec42f16
P1476
A phase 2 trial of dacomitinib
......
or chemotherapy and erlotinib.
@en